Conventus Orthopaedics has completed its acquisition of Flower Orthopedics, the maker of single use, sterile-packaged, implant and instrument kits.
The sterile FlowerCube system eliminates expensive set processing, which enables surgical facilities to complete back-to-back cases, enhance efficiencies, and maximise resources. In addition to a robust fixation portfolio, Flower’s continuum of care also extends into the wound care market for both orthopaedic and podiatric surgeons.
Conventus Orthopaedics developed the platform nitinol CAGE technology to treat proximal humerus and distal radius fractures. Its lower extremity CAGE implant system is currently in development along with a new and innovative distal fibula intramedullary nailing system. Both are expected to accelerate time to weight bearing while reducing complications.
Rick Epstein, Chief Executive Officer of Conventus, commented: “Flower is an excellent strategic fit with Conventus. With ongoing concerns over viral and infection risks associated with heavy reusable orthopaedic implant trays, Flower’s Ready-for-Surgery platform reduces exposure to bioburden while enhancing OR efficiencies.”
“We will continue to develop and acquire innovative products and companies that improve procedures, patient outcomes and safety for orthopaedic and foot and ankle surgeons.”
Conventus intends to continue to aggressively pursue new and innovative orthopaedic technologies that are clinically relevant to surgeons, hospitals and ambulatory surgery centres.